Harvard Apparatus Regenerative Technology Inc. (HRGN)
OTCMKTS · Delayed Price · Currency is USD
1.677
-0.003 (-0.15%)
At close: Mar 19, 2026

HRGN Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
0.70.430.1--
Revenue Growth (YoY)
63.72%317.48%---
Cost of Revenue
0.650.270.02--
Gross Profit
0.060.160.08--
Selling, General & Admin
4.365.146.084.47.12
Research & Development
2.612.242.991.671.52
Operating Expenses
6.977.399.076.078.64
Operating Income
-6.92-7.23-8.99-6.07-8.64
Interest Expense
-0.01-0.04-0.01-0.01-
Interest & Investment Income
0.040.030.06--
Other Non Operating Income (Expenses)
0.02--0.0100.25
EBT Excluding Unusual Items
-6.87-7.23-8.95-6.07-8.39
Other Unusual Items
--0.5--0.41
Pretax Income
-6.87-7.73-8.95-6.07-7.98
Net Income
-6.87-7.73-8.95-6.07-7.98
Preferred Dividends & Other Adjustments
--0.080.18-
Net Income to Common
-6.87-7.73-9.02-6.25-7.98
Shares Outstanding (Basic)
1715131110
Shares Outstanding (Diluted)
1715131110
Shares Change (YoY)
11.68%9.91%18.56%12.79%14.43%
EPS (Basic)
-0.42-0.52-0.67-0.55-0.79
EPS (Diluted)
-0.42-0.52-0.67-0.55-0.79
Free Cash Flow
-3.83-4.85-6.95-5.11-2.63
Free Cash Flow Per Share
-0.23-0.33-0.52-0.45-0.26
Gross Margin
8.24%37.21%76.70%--
Operating Margin
-982.24%-1680.46%-8728.15%--
Profit Margin
-975.71%-1798.14%-8759.22%--
Free Cash Flow Margin
-543.75%-1128.37%-6747.57%--
EBITDA
-6.91-7.21-8.96-6.01-8.53
D&A For EBITDA
0.010.010.040.050.11
EBIT
-6.92-7.23-8.99-6.07-8.64
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.